- Report
- September 2022
- 33 Pages
Global
From €922EUR$995USD£773GBP
- Report
- September 2021
- 80 Pages
Africa
From €1852EUR$2,000USD£1,554GBP
- Report
- September 2021
- 40 Pages
Germany
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
France
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
China
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
Brazil
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
United States
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
South Korea
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
Saudi Arabia
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
Russia
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
Japan
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
Ireland
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
India
From €1389EUR$1,500USD£1,165GBP
- Report
- September 2021
- 40 Pages
Vietnam
From €1389EUR$1,500USD£1,165GBP
- Report
- July 2023
- 100 Pages
Global
From €4492EUR$4,850USD£3,768GBP
- Report
- September 2022
Global
€4990EUR$5,771USD£4,332GBP
- Report
- August 2022
- 67 Pages
Global
- Report
- June 2022
- 58 Pages
Global
- Report
- November 2020
- 450 Pages
Global
From €4539EUR$4,900USD£3,807GBP
- Report
- October 2018
- 386 Pages
Global
From €3751EUR$4,050USD£3,146GBP
T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more